Dayondon, Mary Grace P.

HRN: 25-20-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2026
CEFAZOLIN 1GM (VIAL)
01/04/2026
01/11/2026
IV
1g
Q8h
S/P CS
Checking Final Appropriateness 
01/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2026
01/11/2026
IV
500mg
Q8h
S/P CS
Checking Final Appropriateness 
01/04/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
01/04/2026
01/11/2026
IV
110mg
Now
S/P CS
Checking Final Appropriateness 
01/04/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
01/04/2026
01/11/2026
IV
83mg
OD
S/P CS
Checking Final Appropriateness 
01/06/2026
METRONIDAZOLE 500MG (TAB)
01/06/2026
01/13/2026
PO
500mg
TID
S/p CS
Waiting Final Action 
01/06/2026
CEFUROXIME 500MG (TAB)
01/06/2026
01/13/2026
IVT
500mg
BID
S/p CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: